Greenlane Holdings

GNLN · NASDAQ

$1.82+$0.01 (+0.55%)TodayMarket closed ·
Prev close $1.81

About GNLN

Greenlane Holdings, Inc. engages in the distribution and supply of vaporization products and accessories for vape shops and dispensaries. The company is headquartered in Boca Raton, Florida and currently employs 11 full-time employees. The company went IPO on 2019-04-18. The firm operates as a family of brands, third-party brand accelerator, and an omnichannel distribution platform. The firm offers its own diverse brand portfolio and its licensed Marley Natural and K.Haring branded products. The company also offers a set of third-party products through its direct sales channels and its proprietary, owned and operated e-commerce platforms. Its Greenlane Brands include Groove, its smoke shop and ancillary product brand - Higher Standards, and its child-resistant packaging brand - Pollen Gear. The company merchandises vaporizers, packaging, and other ancillary products in the United States, Canada, Europe, and Latin America. Its third-party brands include Storz and Bickel, Grenco Science, PAX, and Cookies.

Employees
11
Headquarters
Boca Raton, Florida
Listed
Apr 18, 2019
Sector
Consumer Discretionary
Industry
Distributors
Website
gnln.com

GNLN key statistics

Market cap
1.26M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
26.86K
Volume
13.56K
Open price
$1.75
High today
$1.92
Low today
$1.75
52 Week high
$36.24
52 Week low
$1.51

Greenlane Holdings (GNLN) at a glance

Greenlane Holdings (GNLN) last traded at $1.82, with a market cap of 1.26M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.75 and $1.92. The current price is 4.0% above the day's low and 5.0% below its high.

Volume so far is 13.56K shares, below the average of 26.86K shares a day.

Over the past year Greenlane Holdings has ranged from $1.51 to $36.24, and now sits 1% of the way up that range.

Greenlane Holdings met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY23 it reported -$432,960.00 per share against an estimate of -$283,417.19.

GNLN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 42.9% on average.

  1. Q3 FY21: reported -$3,036,000.00 per share against an estimate of -$942,480.00
  2. Q4 FY21: reported -$1,320,000.00 per share against an estimate of -$1,009,800.00
  3. Q1 FY22: reported -$924,000.00 per share against an estimate of -$908,820.00
  4. Q2 FY22: reported -$1,498,200.00 per share against an estimate of -$628,364.88
  5. Q3 FY22: reported -$7,543,800.00 per share against an estimate of -$809,523.00
  6. Q4 FY22: reported -$673,200.00 per share against an estimate of -$1,104,048.00
  7. Q1 FY23: reported -$422,400.00 per share against an estimate of -$793,029.63
  8. Q2 FY23: reported -$432,960.00 per share against an estimate of -$283,417.19

GNLN news

  • 12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

  • 12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

  • 11 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session

  • 12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

Similar companies

Companies in the same industry as Greenlane Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.